摘要:Based on the suppliers and customers globalization, together with the global logistics network improvement and the real time information flow, the companies are being structured under a global manufacturing center model. The country definition of where these centers are going to be located has reached a strategic relevance with a high impact on the business bottom line. In international competition scenario, where usually affiliates from the same organization fight for the investment on manufacturing capacity. The paper aim to indentify the determinants factors to attract international investments to produce drugs in Brazil. The methodology used was the qualitative exploratory research; where a semi-structured survey was send to multinational pharmaceutical industry executives from Boehringer, Johnson & Johnson, Novartis e Wyeth for primary data collection, complemented by bibliography and documental research for secondary data. The main result was the creation of a positive agenda to increase the pharmaceutical industry investment in Brazil, working on the following aspects: a) Professional qualification; b) Logistics infrastructure; c) Industrial infrastructure; d) Regulation; e) Tax system review; e f) Intellectual property.